Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 52 of 298 for:    acne AND moderate

A Bioavailability Study of DFD-03 (Tazarotene, Lotion 0.1 % ) Compared to Tazorac® (Tazarotene), 0.1% in Patients With Moderate Acne Vulgaris

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03599193
Recruitment Status : Completed
First Posted : July 26, 2018
Last Update Posted : October 8, 2019
Information provided by (Responsible Party):
Dr. Reddy's Laboratories Limited

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 30, 2018
Actual Study Completion Date : April 30, 2018
Certification/Extension First Submitted : September 24, 2019